$KTTA 8-K SEC Filings

Filed On	Filing
16 Sep 2026	8-K: Other Events The warrants of Pasithea Therapeutics Corp. (the “Company”) to purchase shares of the Company's common stock, which trade on The Nasdaq Capital Market (“Nasdaq”) under the symbol “KTTAW” (the “Warrants”), will expire on September 17, 202...
09 Sep 2026	8-K: Submission of Matters to a Vote of Security Holders On September 9, 2026, the Company held its Annual Meeting. The stockholders of the Company acted upon the following three proposals at the Annual Meeting: (1) the election of two Class III directors; (2) the ratification of the appointme...
21 Aug 2026	8-K: Notice of Delisting or Failure to Satisfy a Listing Rule
04 May 2026	8-K: Departure/Election of Directors or Officers; Compensation; Regulation FD Disclosure
20 Feb 2026	8-K: Notice of Delisting or Failure to Satisfy a Listing Rule
28 Jan 2026	8-K: Departure/Election of Directors or Officers; Compensation; Amendments to Articles/Bylaws; Change in Fiscal Year +1 more
15 Dec 2025	8-K: Other Events
02 Dec 2025	8-K: Entry into a Material Definitive Agreement; Unregistered Sales of Equity Securities +1 more
25 Nov 2025	8-K: Regulation FD Disclosure; Other Events
04 Nov 2025	8-K: Regulation FD Disclosure; Other Events
27 Oct 2025	8-K: Departure/Election of Directors or Officers; Compensation
16 Sep 2025	8-K: Regulation FD Disclosure; Other Events
03 Sep 2025	8-K: Departure/Election of Directors or Officers; Compensation; Submission of Matters to a Vote of Security Holders
11 Jul 2025	8-K: Shareholder Director Nominations
27 Jun 2025	8-K: Notice of Delisting or Failure to Satisfy a Listing Rule
20 Jun 2025	8-K: Other Events
07 May 2025	8-K: Entry into a Material Definitive Agreement; Regulation FD Disclosure
25 Apr 2025	8-K: Changes in Registrant's Certifying Accountant
26 Nov 2024	8-K: Entry into a Material Definitive Agreement
30 Sep 2024	8-K: Entry into a Material Definitive Agreement; Unregistered Sales of Equity Securities +1 more

Comments